SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-002513
Filing Date
2019-01-18
Accepted
2019-01-18 16:51:25
Documents
1
Period of Report
2019-01-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a19-3165_18k.htm 8-K 23270
  Complete submission text file 0001104659-19-002513.txt   24449
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37691 | Film No.: 19533662
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences